New Generation of Plasmid Backbones Devoid of Antibiotic Resistance Marker for Gene Therapy Trials
Open Access
- 1 November 2011
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 19 (11) , 1942-1949
- https://doi.org/10.1038/mt.2011.182
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Antibiotic-free selection in E. coli: new considerations for optimal design and improved productionMicrobial Cell Factories, 2010
- Novel Antibiotic-Free Plasmid Selection System Based on Complementation of Host Auxotrophy in the NAD De Novo Synthesis PathwayApplied and Environmental Microbiology, 2010
- Novel Minicircle Vector for Gene Therapy in Murine Myocardial InfarctionCirculation, 2009
- Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection systemVaccine, 2009
- Factors affecting plasmid production in Escherichia coli from a resource allocation standpointMicrobial Cell Factories, 2009
- Radioprotection In Vitro and In Vivo by Minicircle Plasmid Carrying the Human Manganese Superoxide Dismutase TransgeneHuman Gene Therapy, 2008
- Plasmid selection in Escherichia coli using an endogenous essential gene markerBMC Biotechnology, 2008
- Efficient expression of vascular endothelial growth factor using minicircle DNA for angiogenic gene therapyJournal of Controlled Release, 2007
- DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune responseNature, 2007
- An array of Escherichia coli clones over-expressing essential proteins: A new strategy of identifying cellular targets of potent antibacterial compoundsBiochemical and Biophysical Research Communications, 2006